Since the decreased intestinal expression of Foxp3, which occurs in IBD and experimental colitis, can impair the intestinal immune tolerance and activate inflammation, it can be assumed that preventing the reduction in Foxp3 expression may alleviate intestinal inflammation [66,69]. This evidence concerns the gene FOXP3 and inflammatory bowel disease.